3419 results for «2024»

Filter By

3419 results

Calcified lesions - LIVE Case

30 Jan 2026 – From SASCI-AfricaPCR

Watch this session if you want to understand the challenges and risks when treating calcified lesions, to learn how to accurately assess coronary calcification, to learn how to utilise the tools available for treating calcified lesions.

LIVE Case from Groote Schuur Hospital Cape Town

Calcified lesions - LIVE Case

Mechanical circulatory support in cardiogenic shock: where are we now?

14 May 2024 – From EuroPCR 2024

In this EuroPCR 2024 interview, Alaide Chieffo and Gabor Toth discuss mechanical circulatory support in cardiogenic shock and myocardial infarction. They address the ECLS-SHOCK trial's lack of benefit from prophylactic ECMO, stressing improved patient selection and timing. They contrast this with the DanGer Shock study, where...

Mechanical circulatory support in cardiogenic shock: where are we now?

Antiplatelet de-escalation after complex PCI: when and how?

14 May 2024 – From EuroPCR 2024

It is now understood that ischemia is not the only risk to consider, as bleeding also plays a significant role. This is why de-escalation is now recommended for patients with complex PCI, as all de-escalation strategies reduce bleeding risk. Discover more about the three different de-escalation...

Antiplatelet de-escalation after complex PCI: when and how?

What is the future role of 3D ICE in tricuspid valve intervention?

26 Nov 2024 – From PCR London Valves 2024

Discover insights on imaging in tricuspid valve management in this engaging PCR London Valves 2024 roundtable discussion with Jennifer Franke, Felix Kreidel, and Azeem Latib.
Explore the potential of 3D intracardiac echocardiography as a cutting-edge tool for advanced imaging, set to transform clinical practice as it adoption...

What is the future role of 3D ICE in tricuspid valve intervention?

Impact of late-breaking clinical evidence on your daily mitral TEER practice

25 Nov 2024 – From PCR London Valves 2024

In this roundtable discussion, Tobias Geisler, Maurizio Taramasso, and Robert Smith delve into the late-breaking trials presented at PCR London Valves 2024. They examine the CLASP IID study, which compares TEER devices for severe mitral regurgitation, and the MiCLASP study, evaluating edge-to-edge therapy approaches. Together, they...

Impact of late-breaking clinical evidence on your daily mitral TEER practice

Mental health in the cathlab: is everything really ok?

14 May 2024 – From EuroPCR 2024

Watch Alison Dahlmann and Kristin Rykkje-Johannessen discuss the impact of working in a cathlab on mental health. Despite limited clinical evidence, a two-month online survey revealed that 93% of cathlab workers, across all healthcare professional categories, find the environment stressful, with over 92% experiencing stress and...

Mental health in the cathlab: is everything really ok?

SCOFF - Fasting or no fasting before cardiac catherisation procedures

03 Sep 2024

Aaysha Cader interviews David Ferreira about the SCOFF trial he presented at the ESC Congress 2024 in London.

Results showed that eating normally before minimally invasive heart procedures did not increase complications and improved patient satisfaction, suggesting a need to reconsider fasting guidelines.

Author

Aaysha Cader
David Ferreira

Author

David Ferreira
SCOFF

NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation

01 Sep 2024

Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.

Author

Chiara De Biase
Jacob Lønborg

Author

Jacob Thomsen Lonborg

Author

Ali Nazmi Calik
NOTION 3

Meet up in the cosy PCR Companions Corner at #PCRLV

07 Nov 2025

Kick-off on 16 November at 08:30 with a fun Welcome Breakfast and live music - in a typically British atmosphere!

Celebrating the passion and dedication of our PCR Companions

RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis

01 Sep 2024

While Chiara De Biase interviews Helene Eltchaninoff about the RHEIA trial results, which she presented at the ESC Congress 2024 in London, Panos Xaplanteris shares his perspective on the trial, offering all the essential information and key takeaways you need for your practice!

Author

Chiara De Biase

Author

Helene Eltchaninoff
Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
RHEIA

How to manage conduction disturbances after tricuspid valve interventions?

20 Mar 2025 – From PCR London Valves 2024

Interested in how to manage conduction disturbances after tricuspid valve interventions? Rodrigo Estevez-Loureiro and Marianna Adamo explore the mechanisms behind this common complication, discuss potential predictors and provide practical strategies for management during and after the procedure

This interview was filmed at PCR London Valves 2024: see...

How to manage conduction disturbances after tricuspid valve interventions?

Asymptomatic severe aortic stenosis, how will new evidence change our practice?

15 May 2024 – From EuroPCR 2024

Victoria Delgado and Martin Leon discuss how to treat patients with asymptomatic severe aortic stenosis at an earlier stage and how current trials may change our practice in the future and broaden the indications.

This interview was filmed at EuroPCR 2024: see more videos here.

Asymptomatic severe aortic stenosis, how will new evidence change our practice?

Focus on PCR Innovators Day

18 Jun 2024 – From EuroPCR 2024

Nicole Karam and Nicolo Piazza highlighted EuroPCR 2024's PCR Innovators Day, which gathered over 400 physicians, ventures, industry partners, and investors to exchange ideas and network. Key topics included valve disease, heart failure, denervation, and the obstacles to innovation across different geographies, addressed in the innovator...

Focus on PCR Innovators Day

Three tailored devices to ease the complex PCI procedures

14 May 2024 – From EuroPCR 2024

At EuroPCR 2024, a round table featuring Jianfang Luo, Benjamin Faurie, and Sevket Gorgulu addresses the challenge of streamlining complex PCI procedures. The discussion focuses on three innovative devices: Expressman™, a guiding extension catheter renowned for its one-piece design and side holes, ensuring adequate antegrade blood...

Three tailored devices to ease the complex PCI procedures

NOTION-2: first TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis

15 May 2024 – From EuroPCR 2024

Christopher Cook interviews Ole de Backer about this study he presented at EuroPCR 2024: It provides further data concerning the 1-year outcome of younger AS patients with tricuspid valve anatomy treated with TAVI compared to SAVR. TAVI and SAVR showed similar rates of the primary endpoint...

NOTION-2: first TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis

How will the SMART trial results impact our practice and decision making in TAVI?

16 May 2024 – From EuroPCR 2024

Sabine Bleiziffer and Didier Tchétché discuss the SMART trial with Flavio Ribichini in this #europcr 2024 roundtable. The trial compares the self-expandable supra-annular EVOLUT platform and the balloon-expandable intra-annular SAPIEN platform in patients with small aortic annulus, prevalent in up to 40% of Europeans, mainly women....

How will the SMART trial results impact our practice and decision making in TAVI?

Strengthening cardiovascular care resilience for healthier hearts: the RESIL-Card project

15 May 2024 – From EuroPCR 2024

In this interview at EuroPCR 2024, William Wijns, Niek Klazinga, and Christopher Cook discuss the RESIL-Card initiative, which emerged from the disruption to cardiovascular care during COVID-19. The initiative aims to use this experience to develop a readiness test for future crises. Extensive data has been collected,...

Strengthening cardiovascular care resilience for healthier hearts: the RESIL-Card project

Learning from the Masters - Key learnings from 20 years of transcatheter edge-to-edge repair

15 May 2024 – From EuroPCR 2024

Maurizio Taramasso interviews Ottavio Alfieri, a pioneering figure in valve surgery and a key contributor to the development of transcatheter edge-to-edge repair, honored with the Ethica Award at the 2024 edition of #europcr. Ottavio Alfieri discusses his journey to becoming a cardiac surgeon, the genesis of...

Learning from the Masters - Key learnings from 20 years of transcatheter edge-to-edge repair

IVORY FINALE study: Low-dose interleukin-2 for the reduction of vascular inflammation in ACS - Clinical outcomes and follow-up

31 Aug 2024

Aaysha Cader interviews Rouchelle Sriranjan about the results of the IVORY and IVORY 2 trials which she presented at the ESC Congress 2024 in London.

The trials examined low-dose interleukin-2 therapy to reduce arterial inflammation in acute coronary syndrome patients. The study found a 7.7% reduction in arterial inflammation...

Author

Aaysha Cader
Rouchelle Sriranjan

Author

Rouchelle Sriranjan

Predictors and clinical relevance of residual tricuspid regurgitation after transcatheter repair

29 Apr 2025 – From PCR London Valves 2024

Curious about the latest advancements in transcatheter tricuspid valve interventions? Don't miss this discussion between Philipp Lurz and Lukas Stolz as they delve into the topic of residual tricuspid regurgitation after transcatheter repair—a challenge that still needs improvement despite significant progress.

This interview was filmed at PCR...

Predictors and clinical relevance of residual tricuspid regurgitation after transcatheter repair
Didn’t find what you were looking for?